The research shows that these immune changes can appear up to a year before a cancer diagnosis, opening new possibilities for early detection.
A team from Clínic-IDIBAPS, within the framework of GeSIDA (AIDS Study Group of the Spanish Society of Infectious Diseases and Clinical Microbiology), has identified a set of immunological and virological alterations that could anticipate cancer development in people living with HIV — even as early as one year before diagnosis.
The study, presented at the 16th National GeSIDA Congress, paves the way for improving the early detection of non-AIDS-defining cancers (NADCs) in this population through more personalized immune monitoring.
Read the full news story here.
Source : Clínic Barcelona
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.